Iñigo Sánchez Rodríguez (Íñigo Sánchez Rodríguez, Iñigo Sánchez-Rodríguez)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 7

Top Topics

Epithelial Mesenchymal Transition

Randomized Controlled Trial

Transforming Growth Factor

Top Venues

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Antonio Tapia-Galisteo, Iñigo Sánchez Rodríguez, Javier Narbona, Patricia Iglesias-Hernández, Saray Aragón-García, Anaïs Jiménez-Reinoso, Marta Compte, Shaukat Khan, Takeshi Tsuda, Patrick Chames, Javier Lacadena, Luis Alvarez-Vallina, Laura Sanz
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses. Oncoimmunology 13 (1) (2024)
Antonio Tapia-Galisteo, Iñigo Sánchez Rodríguez, Javier Narbona, Patricia Iglesias-Hernández, Saray Aragón-García, Anaïs Jiménez-Reinoso, Marta Compte, Shaukat Khan, Takeshi Tsuda, Patrick Chames, Javier Lacadena, Luis Alvarez-Vallina, Laura Sanz
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses. Oncoimmunology 13 (1) (2024)
Antonio Tapia-Galisteo, Iñigo Sánchez Rodríguez, Javier Narbona, Patricia Iglesias-Hernández, Saray Aragón-García, Anaïs Jiménez-Reinoso, Marta Compte, Shaukat Khan, Takeshi Tsuda, Patrick Chames, Javier Lacadena, Luis Alvarez-Vallina, Laura Sanz
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses. Oncoimmunology 13 (1) (2024)
Antonio Tapia-Galisteo, Iñigo Sánchez Rodríguez, Javier Narbona, Patricia Iglesias-Hernández, Saray Aragón-García, Anaïs Jiménez-Reinoso, Marta Compte, Shaukat Khan, Takeshi Tsuda, Patrick Chames, Javier Lacadena, Luis Alvarez-Vallina, Laura Sanz
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses. Oncoimmunology 13 (1) (2024)
Antonio Tapia-Galisteo, Iñigo Sánchez Rodríguez, Javier Narbona, Patricia Iglesias-Hernández, Saray Aragón-García, Anaïs Jiménez-Reinoso, Marta Compte, Shaukat Khan, Takeshi Tsuda, Patrick Chames, Javier Lacadena, Luis Alvarez-Vallina, Laura Sanz
Combination of T cell-redirecting strategies with a bispecific antibody blocking TGF-β and PD-L1 enhances antitumor responses. Oncoimmunology 13 (1) (2024)
Antonio Tapia-Galisteo, Iñigo Sánchez Rodríguez, Oscar Aguilar-Sopeña, Seandean Lykke Harwood, Javier Narbona, Mariola Ferreras-Gutierrez, Rocío Navarro, Laura Martín-García, Cesáreo Corbacho, Marta Compte, Javier Lacadena, Francisco J Blanco, Patrick Chames, Pedro Roda-Navarro, Luis Alvarez-Vallina, Laura Sanz
Trispecific T-cell engagers for dual tumor-targeting of colorectal cancer. Oncoimmunology 11 (1) (2022)
Gabriele Picco, Chiara Maria Cattaneo, Esmée J van Vliet, Giovanni Crisafulli, Giuseppe Rospo, Sarah Consonni, Sara F Vieira, Iñigo Sánchez Rodríguez, Carlotta Cancelliere, Ruby Banerjee, Luuk J Schipper, Daniele Oddo, Krijn K Dijkstra, Jindrich Cinatl, Martin Michaelis, Fengtang Yang, Federica Di Nicolantonio, Andrea Sartore-Bianchi, Salvatore Siena, Sabrina Arena, Emile E Voest, Alberto Bardelli, Mathew J Garnett, null null
Werner Helicase Is a Synthetic-Lethal Vulnerability in Mismatch Repair-Deficient Colorectal Cancer Refractory to Targeted Therapies, Chemotherapy, and Immunotherapy. Cancer discovery 11 (8) (2021)